Title |
Why the MDGs need good governance in pharmaceutical systems to promote global health
|
---|---|
Published in |
BMC Public Health, January 2014
|
DOI | 10.1186/1471-2458-14-63 |
Pubmed ID | |
Authors |
Jillian Clare Kohler, Tim Ken Mackey, Natalia Ovtcharenko |
Abstract |
Corruption in the health sector can hurt health outcomes. Improving good governance can in turn help prevent health-related corruption. We understand good governance as having the following characteristics: it is consensus-oriented, accountable, transparent, responsive, equitable and inclusive, effective and efficient, follows the rule of law, is participatory and should in theory be less vulnerable to corruption. By focusing on the pharmaceutical system, we explore some of the key lessons learned from existing initiatives in good governance. As the development community begins to identify post-2015 Millennium Development Goals targets, it is essential to evaluate programs in good governance in order to build on these results and establish sustainable strategies. This discussion on the pharmaceutical system illuminates why. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 31% |
Canada | 2 | 15% |
Venezuela, Bolivarian Republic of | 1 | 8% |
United Kingdom | 1 | 8% |
Unknown | 5 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 69% |
Scientists | 3 | 23% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 121 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 21 | 17% |
Researcher | 15 | 12% |
Student > Ph. D. Student | 15 | 12% |
Student > Bachelor | 11 | 9% |
Student > Doctoral Student | 5 | 4% |
Other | 16 | 13% |
Unknown | 38 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 12% |
Business, Management and Accounting | 12 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 9% |
Economics, Econometrics and Finance | 10 | 8% |
Social Sciences | 9 | 7% |
Other | 25 | 21% |
Unknown | 39 | 32% |